ID23435A - Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns - Google Patents

Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns

Info

Publication number
ID23435A
ID23435A IDW990935D ID990935D ID23435A ID 23435 A ID23435 A ID 23435A ID W990935 D IDW990935 D ID W990935D ID 990935 D ID990935 D ID 990935D ID 23435 A ID23435 A ID 23435A
Authority
ID
Indonesia
Prior art keywords
neurodegeratives
attropisomers
heteroaril
quinazolinone
cns
Prior art date
Application number
IDW990935D
Other languages
English (en)
Indonesian (id)
Inventor
Bertrand Leo Chenard
Keith Michael De Vries
Willard Mckowan Welch Jr
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID23435A publication Critical patent/ID23435A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW990935D 1997-02-28 1998-02-06 Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns ID23435A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3854097P 1997-02-28 1997-02-28

Publications (1)

Publication Number Publication Date
ID23435A true ID23435A (id) 2000-04-20

Family

ID=21900535

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990935D ID23435A (id) 1997-02-28 1998-02-06 Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns

Country Status (40)

Country Link
US (1) US6380204B1 (tr)
EP (1) EP0964860B1 (tr)
JP (1) JP3299990B2 (tr)
KR (1) KR20000075812A (tr)
CN (1) CN1248254A (tr)
AP (1) AP9801202A0 (tr)
AR (1) AR011886A1 (tr)
AT (1) ATE264854T1 (tr)
AU (1) AU732448B2 (tr)
BG (1) BG103687A (tr)
BR (1) BR9807807A (tr)
CA (1) CA2282279C (tr)
CO (1) CO4950615A1 (tr)
DE (1) DE69823339T2 (tr)
DK (1) DK0964860T3 (tr)
DZ (1) DZ2438A1 (tr)
EA (1) EA001961B1 (tr)
ES (1) ES2218801T3 (tr)
GT (1) GT199800039A (tr)
HN (1) HN1998000028A (tr)
HR (1) HRP980108B1 (tr)
HU (1) HUP0000935A3 (tr)
ID (1) ID23435A (tr)
IL (1) IL130897A0 (tr)
IS (1) IS5141A (tr)
MA (1) MA24485A1 (tr)
NO (1) NO994178D0 (tr)
NZ (1) NZ336627A (tr)
OA (1) OA11088A (tr)
PA (1) PA8446901A1 (tr)
PE (1) PE57999A1 (tr)
PL (1) PL335307A1 (tr)
PT (1) PT964860E (tr)
SK (1) SK113199A3 (tr)
TN (1) TNSN98034A1 (tr)
TR (1) TR199902094T2 (tr)
TW (1) TW530055B (tr)
UA (1) UA58536C2 (tr)
WO (1) WO1998038187A1 (tr)
ZA (1) ZA981665B (tr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323208B1 (en) 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
JPH11279158A (ja) * 1998-02-09 1999-10-12 Pfizer Prod Inc キナゾリン―4―オン誘導体の製造方法
US6890930B1 (en) * 1999-09-28 2005-05-10 3-Dimensional Pharmaceuticals, Inc. Quinazolinones
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents
CA2534405A1 (en) * 2003-08-08 2005-02-17 Ulysses Pharmaceutical Products Inc. Halogenated quinazolinyl nitrofurans as antibacterial agents
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7893260B2 (en) 2005-11-04 2011-02-22 Hydra Biosciences, Inc. Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
AU2007303846B2 (en) * 2006-10-04 2011-03-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists
WO2008140750A1 (en) * 2007-05-10 2008-11-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
NZ595307A (en) * 2009-03-24 2013-11-29 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
EP2435048B1 (en) * 2009-05-29 2019-07-03 Merck Sharp & Dohme Corp. Radiolabeled pde10 inhibitors
WO2013105985A1 (en) * 2011-02-28 2013-07-18 Philadelphia Health & Education Corporation Small molecule inhibitors of rad51 recombinase and methods thereof
BR112022014933A2 (pt) 2020-01-29 2022-09-20 Kamari Pharma Ltd Compostos e composições para uso no tratamento de distúrbios de pele

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298603A (en) * 1970-04-06 1972-12-06 Karamchand Premchand Private Quinazolinone derivatives
US4183931A (en) * 1977-09-08 1980-01-15 Research Corporation 2-Ketoalkyl-4(3H)-quinazolinones
WO1992013535A1 (en) * 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
ATE227293T1 (de) * 1996-05-15 2002-11-15 Pfizer 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
DK0901487T3 (da) 1996-05-15 2003-08-25 Pfizer 2,3,6-trisubstituerede 4(3H)-quinazolinoner

Also Published As

Publication number Publication date
KR20000075812A (ko) 2000-12-26
GT199800039A (es) 1999-08-13
PL335307A1 (en) 2000-04-10
IL130897A0 (en) 2001-01-28
CO4950615A1 (es) 2000-09-01
CA2282279A1 (en) 1998-09-03
PT964860E (pt) 2004-07-30
ATE264854T1 (de) 2004-05-15
TNSN98034A1 (fr) 2005-03-15
OA11088A (en) 2002-03-15
PE57999A1 (es) 1999-06-21
JP3299990B2 (ja) 2002-07-08
DK0964860T3 (da) 2004-07-26
UA58536C2 (uk) 2003-08-15
CN1248254A (zh) 2000-03-22
DE69823339T2 (de) 2005-05-12
HRP980108A2 (en) 1998-12-31
EP0964860B1 (en) 2004-04-21
DE69823339D1 (de) 2004-05-27
HN1998000028A (es) 1999-02-09
JP2000509732A (ja) 2000-08-02
BG103687A (en) 2000-06-30
ZA981665B (en) 1999-08-17
TW530055B (en) 2003-05-01
AU732448B2 (en) 2001-04-26
NO994178L (no) 1999-08-27
HRP980108B1 (en) 2004-10-31
HUP0000935A2 (hu) 2001-04-28
CA2282279C (en) 2004-11-02
IS5141A (is) 1999-07-30
EA199900689A1 (ru) 2000-02-28
HUP0000935A3 (en) 2002-04-29
WO1998038187A1 (en) 1998-09-03
DZ2438A1 (fr) 2003-01-11
EA001961B1 (ru) 2001-10-22
SK113199A3 (en) 2001-10-08
AP9801202A0 (en) 1999-08-26
US6380204B1 (en) 2002-04-30
NZ336627A (en) 2000-12-22
ES2218801T3 (es) 2004-11-16
NO994178D0 (no) 1999-08-27
PA8446901A1 (es) 2000-05-24
EP0964860A1 (en) 1999-12-22
MA24485A1 (fr) 1998-10-01
BR9807807A (pt) 2000-02-22
AU5775998A (en) 1998-09-18
TR199902094T2 (tr) 1999-12-21
AR011886A1 (es) 2000-09-13

Similar Documents

Publication Publication Date Title
ID23435A (id) Atropisomer dari 3-heteroaril-4(3h)-kuinazolinon untuk pengobatan neurodegeratif dan kondisi-kondisi yang terkait dengan trauma-cns
ID22711A (id) Atropisomer dari 3-aril-4(3h)-kinazolinon dan penggunaannya sebagai antagonis reseptor-ampa
ID24202A (id) Multi-fase agregat yang terdiri dari karbon dan preparasinya
ID22389A (id) Komposisi dan metode untuk menurunkan hipertensi okuler
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
DE69634822D1 (de) Amid-verbindungen und ihre anwendung
AU2002236438A1 (en) Compositions and methods for treatment of mild cognitive impairment
IT1283046B1 (it) Procedimento per riconoscere mancate combustioni
ID27502A (id) Turunan-turunan 3-(amino-atau aminoalkil) piridinon dan penggunannya untuk pengobatan penyakit-penyakit yang berkaitan dengan hiv
IS5510A (is) Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða
AU7165798A (en) Use of genistein and related compounds to treat certain sex hormone related conditions
ID20973A (id) Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
IT1283827B1 (it) Procedimento per riconoscere mancate combustioni
DE69836209D1 (de) Vorbeugung und behandlunhg des hepatozellulären krebses
ID20819A (id) Semaforin l manusia (h-sema l) dan semaforin yang sesuai dalam spesies lainnya
ID28277A (id) Komposisi-komposisi yang terdiri dari analog-analog gaba dan kaffein
ID22449A (id) Campuran zat dapat yang didasarkan pada sulfonil dan adjuvan
IT1290561B1 (it) Procedimento per riconoscere mancate combustioni
DE59912433D1 (de) Vorverzerrung zur verringerung von intersymbolinterferenz sowie mehrfachzugriffsinterferenz
ID27066A (id) Proses yang disempurnakan untuk ko-produksi dari 6-aminokapronitril dan heksametilendiamina
ID22345A (id) Penghilangan 6-aminokapronitril dari campuran-campuran yang terdiri dari 6-aminokapronitril dan suatu imina
IT1282569B1 (it) Procedimento per riconoscere mancate combustioni
DE69605010T2 (de) Trifluormethansulfinanilidverbindung und ihre Anwendung
ID22685A (id) Penghilangan 6-aminokapronitril dari campuran yang terdiri dari 6-aminokapronitril dan imina